by Truveta staff | Sep 26, 2024 | Technology
Despite advances in guideline-directed medical therapy, heart failure (HF) readmission rates have worsened over the past decade. Optimizing acute inpatient decongestion is critical in mitigating HF morbidity and mortality, but few new treatment strategies have emerged...
by Truveta Research | Mar 6, 2024 | Research, Research Insights
Disparities in time to treatment and treatment outcomes exist for people with severe aortic stenosis receiving TAVR and SAVR procedures. We studied the rate of people who receive TAVR, SAVR, aortic valve repair, and aortic balloon valvuloplasty procedures and time to...
by Truveta staff | Feb 15, 2023 | News, Research
The United States is one of the most dangerous high-income countries in which to give birth. Nearly every negative maternal health outcome impacts women of color more than white women. This February, in honor of Heart Health Month and Black History Month, Truveta...
by Truveta staff | Feb 14, 2023 | Technology
It’s no secret — yet surprising and tragic — that the United States is one of the most dangerous high-income countries in which to give birth. It’s also unfortunately well known that nearly every maternal health outcome in the United States negatively affects women of...
by Truveta Research | Feb 7, 2023 | Research, Research Insights
Among women with preeclampsia, new Truveta Research findings show that Black women are two times more likely to experience heart failure than white women. Maternal health outcomes in the US are worse than in many other high-income countries such as England, France,...
